Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Novel Soy Germ Pasta Improves Gastric Emptying Time
Findings in patients with type 2 diabetes, compared to consumption of regular pasta

WEDNESDAY, Aug. 14 (HealthDay News) -- Pasta enriched with biologically active isoflavone aglycons significantly improves gastric emptying time in patients with type 2 diabetes, according to a pilot study published online July 8 in Diabetes Care.

Kenneth D.R. Setchell, Ph.D., from Cincinnati Children's Hospital, and colleagues randomized 10 patients with delayed gastric emptying to consume one serving per day of soy germ pasta and conventional pasta for eight weeks, with a four-week washout. The [13C]octanoic acid breath test was used at baseline and after each period to measure gastric emptying time (t1/2). Blood glucose and insulin concentrations were determined after oral glucose load.

The researchers found that soy germ pasta significantly accelerated the t1/2 in these patients, from baseline to after treatment. This change is gastric emptying time was significantly accelerated compared to that for conventional pasta, without affecting glucose or insulin concentrations.

"These findings suggest that soy germ pasta may offer a simple dietary approach to managing diabetic gastropathy," the authors write.

Two authors disclosed financial ties to Aliveris, a manufacturer of soy germ pasta.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.

August 2, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

CMS Recognizes Telehealth in New Physician Fee Schedule

FDA Approves Jardiance for Type 2 Diabetes

Healthy Lifestyle Cuts Metabolic Syndrome Risk in CA Survivors CME

Two New Radiographic Signs of Gastric Band Slippage ID'd CME

Slow Progress Toward Meaningful Use Stage 2

HCV Genotype 1 Is Most Prevalent Globally